Pfizer accused of profiteering after reporting further leap in Covid vaccine salesProactive Investors • 05/04/22
Pfizer revenue growth soars 77% as PFE beats earnings estimates by almost $1 billionFinbold • 05/04/22
Pfizer, Inc. (PFE) CEO Albert Bourla on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/03/22
Called to Account: Drug companies are making an accounting change after the SEC cracked down on BiogenMarket Watch • 05/03/22
Paxlovid prescriptions to treat Covid increased tenfold in U.S. since late February, Pfizer saysCNBC • 05/03/22
Pfizer Stock Flies Higher Following Q1 Earnings Print: Here's What To Watch For NextBenzinga • 05/03/22
Pfizer leaves 2022 COVID-19 product sales forecasts unchanged in 1Q reportProactive Investors • 05/03/22
Pfizer reports combined sales of $15 billion for Covid vaccine and antiviral treatment in first quarterCNBC • 05/03/22